Caixin
Oct 10, 2022 10:45 PM
WORLD

Analysis: How a Chinese mRNA Covid Vaccine Was Approved in Indonesia

Indonesia's President Joko Widodo (center right) attends the opening of Etana's mRNA vaccine production site on Friday. Photo: Etana Biotech
Indonesia's President Joko Widodo (center right) attends the opening of Etana's mRNA vaccine production site on Friday. Photo: Etana Biotech

Indonesia will use Chinese technology to locally produce Chinese-developed mRNA Covid-19 vaccine AWcorna in a quest to become more self-sufficient in dealing with the virus.

The Southeast Asian country’s daily case tally had dropped to about 1,000 on Sunday, according to data from Johns Hopkins University. The country’s President Joko Widodo said the rollout will allow Indonesia to “respond more calmly to Covid outbreaks in the future.”

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin-Sinica Business Brief: China Mourns Death of Former President Jiang Zemin
00:00
00:00/00:00